Related Experiment Videos
A randomised placebo-controlled trial of the effects of midazolam premedication on children's postoperative cognition
K Millar1, A J Asbury, A W Bowman
1University of Glasgow, Section of Psychological Medicine, Gartnavel Royal Hospital, 1055 Great Western Road, Glasgow G12 0XH, UK. k.millar@clinmed.gla.ac.uk
Insights
Low-dose midazolam premedication significantly impairs children's postoperative cognitive function, including reaction time and memory. These cognitive deficits, particularly amnesia, persist for up to 48 hours after dental surgery.
Area of Science:
- Pediatric Anesthesiology
- Cognitive Neuroscience
- Pharmacology
Background:
- Midazolam is commonly used for premedication in pediatric anesthesia.
- Its effects on postoperative cognitive function in children require thorough investigation.
- Understanding these effects is crucial for optimizing perioperative care.
Purpose of the Study:
- To evaluate the impact of midazolam premedication on children's cognitive function post-surgery.
- To assess the duration of any observed cognitive impairments and amnesia.
Main Methods:
- A randomized, placebo-controlled trial involving 179 children aged 5-10 years.
- Participants received either buccal midazolam (0.2 mg/kg) or placebo before sevoflurane-nitrous oxide anesthesia for dental extractions.
- Cognitive tests (reaction time, attention, psychomotor coordination, memory) were administered pre-operatively, before discharge, and at 48 hours post-surgery.
Main Results:
- Midazolam group showed significantly slower reaction times and impaired psychomotor coordination compared to placebo postoperatively.
- Significant anterograde amnesia was observed in the midazolam group, persisting for 48 hours.
- Cognitive function and reaction time returned to baseline levels by 48 hours post-surgery for both groups.
Conclusions:
- Low-dose midazolam premedication leads to short-term cognitive impairment in children.
- Anterograde amnesia following midazolam can endure for at least 48 hours.
- These findings highlight potential risks associated with midazolam use in pediatric surgical settings.
Abstract:
This randomised, placebo-controlled study assessed the effects of midazolam premedication on children's postoperative cognition and physical morbidity. In all, 179 children aged 5-10 years were randomly assigned to receive buccal midazolam (0.2 mg x kg(-1)) or placebo before sevoflurane-nitrous oxide anaesthesia for multiple dental extractions. They performed tests of choice reaction time, attention, psychomotor co-ordination and memory pre-operatively (baseline), before discharge and at 48 h. The reaction time of both groups was significantly slower before discharge compared to baseline, with the midazolam group being significantly slower than placebo. Psychomotor co-ordination was also significantly impaired postoperatively after midazolam. Performance on both tests had recovered to baseline by 48 h. Midazolam was also associated with significant anterograde amnesia, both postoperatively and at 48 h, for information presented in the interval between premedication and surgery. The results show significant short-term impairment of children's cognitive function and amnesia enduring for 48 h after low-dose midazolam premedication.
Related Concept Videos
Parenteral Anesthetics: Overview
Blind Procedures
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Stages of General Anesthesia